How Big Pharma Is Turning Industrial Heat Into A Strategic Asset

How Big Pharma Is Turning Industrial Heat Into A Strategic Asset
AstraZeneca's Clean Heat Program is turning industrial heat decarbonization into a hedge against energy volatility — and a core business strategy.